About Sava: A Pioneering Pain-Free Health Monitoring

Revolutionizing Healthcare Startup: Meet Sava .The startup unveiling a game-changing microsensor for painless health monitoring! Led by CEO Renato Circi and co-founders Rafaël Michali, The Revolutionary Leaders drive Innovation in HealthCare Industry

Sava A developed microsensing device to detect molecules in the interstitial fluid, just under the skin. Its smart, connected wearable patch has been designed to streamline this data and deliver it directly to a user’s phone. The microsensor offers pain-free, real-time insights for users at a more affordable price.

It tackles preventable illness by building a new operating system for health monitoring also its sensor will be able to monitor multiple molecules simultaneously.

This Multi-analyte sensing unlocks the ability to monitor a vast range of conditions from chronic conditions to next-gen well-being applications, drug adherence to personalized therapy, and more. The company aims to power the next era of healthcare with this offering

Sava‘s microsensor, approved by the UK’s MHRA, promises real-time insights into glucose levels—just the beginning. With plans for multi-analyte sensing, it aims to monitor various conditions, from chronic diseases to personalized therapies, all via a smart wearable patch directly to your phone. 📲

Funding Detail

Recently Sava has secured $8M in Seed funding from Balderton Capital and Exor Ventures to propel its vision forward.

This funding will fuel team expansion, advanced product development, and clinical validation, marking a significant step towards accessible, high-quality health monitoring for all.